The emerging approach of the medication represents a major development in the handling of type 2 diabetes. Different to existing therapies, tirzepatide affects multiple pathways – GLP-1 and GIP – leading to https://tirzepatide-peptide482938.eedblog.com/42293374/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment